Part of the benefit from psychedelic medicine may actually be a Placebo Effect. Find out why that is actually a GOOD thing.
Exploring the companies and themes that make up this emerging and exciting new sector
Lifetime psychedelic use may reduce likelihood of hypertension
Lifetime classic psychedelic use, particularly tryptamines, may be linked to lower odds for hypertension in the previous year, according to data published in Hypertension.
Psychedelics research: Scientists zero in on the ideal dose of LSD to use in psychiatric treatment
New research published in Neuropsychopharmacology provides insight into the acute dose dependent effects of LSD.
COMPASS Pathways plc announces financial results and business highlights for fourth quarter and year-end 2020
Compass expecting to report data from its Phase IIb study by the end of 2021. Cash on hand decreases to $190.3 million, from $196.5 million the previous quarter.
Cybin Announces API Synthesis and Optimization of Multiple Tryptamine Derivatives and Nomination of Two Deuterated Candidates for Full IND Enabling Studies Based on Second Milestone Achievement Pursuant to the Adelia Acquisition
Adelia Therapeutics, a subsidiary of Cybin Corp., achieves API synthesis and optimization on trypatmine derivatives.
Red Light Holland's Psychedelic Virtual Reality Experience, Wisdom, Narrated by Global Comedy Superstar Russell Peters, Accepted to Steam, the Largest Digital Distribution Platform for PC Gaming
Red Light Holland gets its VR "experience" hosted on the largest PC gaming platform.
WATCH - Mydecine Co-Founder Damon Michaels: It’s Time To Make Alternative Medicine Traditional Medicine
Damon Michaels, chief operating officer of emerging biotech and life sciences company Mydecine sat down with The Dales Report last week to discuss the company’s latest activity.
New York Lawmaker Files Bill To Decriminalize Psilocybin Mushrooms
A New York lawmaker is proposing to decriminalize psychedelic mushrooms in the state.
MindMed Announces C$19.5 Million Bought Deal Private Placement Offering
MindMed raises CAD$19.5 million selling units at CAD$3.25.
Previous antidepressant use may blunt the effectiveness of MDMA-assisted psychotherapy for PTSD
New research suggests that MDMA-assisted therapy for the treatment of posttraumatic stress disorder (PTSD) is less effective among those who have recently used selective serotonin reuptake inhibitors (SSRIs), a common psychiatric medication.
The Race to Patent Psychedelics Is Just Getting Started
The author and podcast host Tim Ferriss has done his share of heavy lifting when it comes to supporting and promoting research on psychedelic drugs.
Local Activists In Washington State Push For Psilocybin Decriminalization
Voters in Spokane, Washington could make the city one of the latest to decriminalize psilocybin mushrooms under a proposed ordinance that was recently filed by local activists.